<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03345771</url>
  </required_header>
  <id_info>
    <org_study_id>17-00496</org_study_id>
    <nct_id>NCT03345771</nct_id>
  </id_info>
  <brief_title>Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty</brief_title>
  <official_title>Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether an occlusive antimicrobial barrier dressing&#xD;
      or portable negative pressure wound dressing is superior in preventing wound complications&#xD;
      and infection rates in obese patients undergoing total joint arthroplasty (TJA).&#xD;
      Approximately 240 subjects (120 for total knee arthroplasty and 120 for total hip&#xD;
      arthroplasty) will be enrolled to evaluate the outcomes associated with silver impregnated&#xD;
      dressings and negative pressure wound therapy (NPWT) in treating this subset of patients and&#xD;
      analyze the cost benefit of each.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 13, 2017</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Actual">April 1, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analog Scale (VAS) pain score</measure>
    <time_frame>Day 8</time_frame>
    <description>0 = worst possible scar, 100 = best possible scar</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wound Evaluation Scale (WES)</measure>
    <time_frame>Day 8</time_frame>
    <description>Wound Evaluation Scale*&#xD;
Stepoff borders (0 for yes, 1 for no)&#xD;
Contour irregularity-puckering&#xD;
Scar width-greater than 2 mm&#xD;
Edge inversion-sinking, curling&#xD;
Inflammation-redness, discharge&#xD;
Overall cosmesis (0 = poor, 1 = acceptable) *6/6 = optimal wound healing.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">230</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Antimicrobial Barrier Dressing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>postoperative wound dressing with either anti-microbial dressing placed in the operating room from surgery to postoperative day 7</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Closed-incision Negative Pressure Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>portable NPWT device placed in the operating room from surgery to postoperative day 7</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Antimicrobial Barrier Dressing</intervention_name>
    <description>Ionic Silver is a soft, nonwoven pad or ribbon that features the gelling benefits of Hydrofiber technology plus antimicrobial ionic silver.</description>
    <arm_group_label>Antimicrobial Barrier Dressing</arm_group_label>
    <other_name>AQUACEL Ag Hydrofiber Dressing</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Negative Pressure Wound Therapy (NPWT)</intervention_name>
    <description>PICO provides suction known as negative Pressure wound Therapy (NPWT) which draws out excess fluid from a wound and protects the injured area from getting dirty to ultimately help promote healing. PICO consists of an nPwT pump connected to an absorbent gentle adhesive dressing</description>
    <arm_group_label>Closed-incision Negative Pressure Therapy</arm_group_label>
    <other_name>PICO</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Those identified at pre-operative testing to have an elevated BMI (&gt; 35)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active infection&#xD;
&#xD;
          -  previous scar or wound healing complication&#xD;
&#xD;
          -  post traumatic degenerative joint disease (DJD) with hardware&#xD;
&#xD;
          -  revision surgery&#xD;
&#xD;
          -  inflammatory arthritis&#xD;
&#xD;
          -  anticoagulation outside of the standard of care.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ran Schwarzkopf, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>November 14, 2017</study_first_submitted>
  <study_first_submitted_qc>November 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2017</study_first_posted>
  <last_update_submitted>May 4, 2021</last_update_submitted>
  <last_update_submitted_qc>May 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Infective Agents</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

